Avalyn Pharma: Avalyn to Participate in Upcoming Investor Conference in April
CAMBRIDGE, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management will participate in the Citi Biotech Private Access Day.Format: 1x1 MeetingsDate: Thursday, April 24, 2025Location:
Read full article »
Avalyn is a Washington-based biopharmaceutical company that researches and develops novel therapies for the treatment of respiratory diseases.
Read more